N
Nicole E. Carmona
Researcher at Ryerson University
Publications - 34
Citations - 852
Nicole E. Carmona is an academic researcher from Ryerson University. The author has contributed to research in topics: Major depressive disorder & Insomnia. The author has an hindex of 12, co-authored 25 publications receiving 510 citations. Previous affiliations of Nicole E. Carmona include University Health Network & Inje University.
Papers
More filters
Journal ArticleDOI
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
Roger S. McIntyre,Mehala Subramaniapillai,Yena Lee,Yena Lee,Zihang Pan,Zihang Pan,Nicole E. Carmona,Margarita Shekotikhina,Margarita Shekotikhina,Joshua D. Rosenblat,Joshua D. Rosenblat,Elisa Brietzke,Elisa Brietzke,Joanna K. Soczynska,Victoria E. Cosgrove,Shefali Miller,Eileen Grace Fischer,Nicole E. Kramer,Kiley Dunlap,Trisha Suppes,Rodrigo B. Mansur,Rodrigo B. Mansur +21 more
TL;DR: Infliximab did not significantly reduce depressive symptoms compared with placebo in adults with bipolar depression, and a significant treatment-time and childhood maltreatment interaction was observed in which infliximab-treated individuals with childhood history of physical abuse exhibited greater reductions in MADRS total score.
Journal ArticleDOI
Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Carola Rong,Yena Lee,Nicole E. Carmona,Danielle S. Cha,Renee-Marie Ragguett,Joshua D. Rosenblat,Rodrigo B. Mansur,Roger C.M. Ho,Roger S. McIntyre +8 more
TL;DR: Existing literature provides empirical support for the hypothesis that CBD may exert beneficial effects on brain effector systems/substrates subserving domain‐based phenomenology, and calls for target‐engagement proof‐of‐principle studies using the research domain criteria (RDoC) framework.
Journal ArticleDOI
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.
Roger S. McIntyre,Roger S. McIntyre,Michael W. Best,Christopher R. Bowie,Christopher R. Bowie,Nicole E. Carmona,Danielle S. Cha,Danielle S. Cha,Yena Lee,Yena Lee,Mehala Subramaniapillai,Rodrigo B. Mansur,Harry Barry,Bernhard T. Baune,Larry Culpepper,Philippe Fossati,Tracy L. Greer,Catherine J. Harmer,Esther Klag,Raymond W. Lam,Hans-Ulrich Wittchen,John Harrison,John Harrison +22 more
TL;DR: The THINC-it is a valid and sensitive tool for detecting cognitive dysfunction in adults withMDD that is free, easy to use, and rapidly administered and should be incorporated into the assessment and measurement of all patients with MDD.
Journal ArticleDOI
Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.
Yena Lee,Joshua D. Rosenblat,Jung Goo Lee,Nicole E. Carmona,Mehala Subramaniapillai,Margarita Shekotikhina,Rodrigo B. Mansur,Elisa Brietzke,Jae-Hon Lee,Roger C.M. Ho,Samantha J. Yim,Roger S. McIntyre +11 more
TL;DR: Extant data suggest that antidepressant treatment improves workplace outcomes in MDD and the capability of antidepressants in improving measures of workplace functioning should be considered in cost-benefit analyses to better inform cost-modelling studies pertaining to antidepressant therapy.
Journal ArticleDOI
Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry.
Andy M.Y. Tai,Alcides Albuquerque,Nicole E. Carmona,Mehala Subramanieapillai,Danielle S. Cha,Margarita Sheko,Yena Lee,Rodrigo B. Mansur,Roger S. McIntyre,Roger S. McIntyre +9 more
TL;DR: Results indicate that AI is a viable option to build useful predictors of outcome while offering objective and comparable accuracy metrics, a unique opportunity, particularly in mental health research.